Av Vania Morelli
Forsker ved TREC
Anticoagulants, commonly referred to as blood thinners, are drugs used to prevent the
formation of blood clots in the blood vessels or in the heart. A new generation of drugs, the so-called direct oral anticoagulants (DOACs), has emerged as an interesting alternative to warfarin, a well-known anticoagulant by clinicians, for oral anticoagulation. A new study searched for a therapeutic strategy to manage life-threatening bleeding in patients who use DOACs.
By Sigrid Brækkan, Associate Professor TREC
Obesity is associated with increased risk of blood clots (thrombosis). The mechanism behind this association remains unclear, but studies have shown that overweight and obese subjects display higher levels of several components of the coagulation system. 
If the risk of blood clots in obese is caused by increased coagulation activity, one would expect that obese people are protected against bleeding. However, is this the case? Do obese people bleed less frequently than those that are normal weight? Continue reading
